Clinical Trial Update: UARK 89-001 Phase II Study of Intensive "TOTAL THERAPY" For Untreated or Minimally Treated Patients With Multiple Myeloma [Phase 2]

View source ↗

Summary

Phase II trial update of an intensive TOTAL THERAPY regimen for untreated or minimally treated multiple myeloma; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Snippet

Sponsor: University of Arkansas | Conditions: Multiple Myeloma | Phase 2 | Status: COMPLETED | Results posted: 2016-09-20